Xylem (XYL) stock is in focus after the company raised its 2026 revenue outlook to US$9.2b to US$9.3b and reported first quarter revenue and net income above the prior year.

The revenue outlook upgrade and stronger first quarter results have not yet translated into strong recent momentum. The 30 day share price return shows a decline of 4.25% and the year to date share price return shows a decline of 13.51%, while the 3 year total shareholder return of 15.11% points to a more resilient longer term picture.

If you like the theme of water and infrastructure but want to see what else is out there, take a look at 34 power grid technology and infrastructure stocks

So with solid revenue and earnings figures, a higher 2026 outlook, and the stock still below both recent highs and analyst targets, is Xylem now trading at an attractive entry point, or is the market already pricing in future growth?

Most Popular Narrative: 22.4% Undervalued

At a last close of $118.59 against a narrative fair value of $152.82, Xylem is framed as undervalued, with that gap resting on detailed growth and margin assumptions.

Successful post-acquisition integration of Evoqua and revenue synergies from services expansion are accelerating Xylem's shift toward more recurring, higher-margin aftermarket and services revenue streams, boosting earnings stability and long-term profitability.

Curious what kind of revenue mix and margin profile need to hold up to support that fair value? The narrative leans on steady growth assumptions, rising profitability, and a future earnings multiple that has to stack up against the broader machinery group. Result: Fair Value of $152.82 (UNDERVALUED)

However, this hinges on municipal funding and project timing holding up, and any stumble in integrating acquisitions like Evoqua could quickly challenge the current undervalued narrative.

Another Angle on Valuation

The narrative fair value and analyst targets lean on earnings growth and margins, but the current 28.7x P/E presents a more cautious picture. Xylem trades roughly in line with its 28.7x fair ratio and above the 28x US Machinery average. That leaves less obvious room for multiple expansion if sentiment turns.

For investors, that raises a simple question: is this a quality stock priced fairly, or a case where expectations leave limited margin for error when execution or funding cycles wobble?

Next Steps

Does the mix of optimism and caution here match your own read, or does it raise more questions for you about Xylem's potential rewards? If you want to move quickly from headlines to hard data and see what others are optimistic about, take a closer look at the 5 key rewards

Looking for more investment ideas?

If you stop at a single stock, you risk missing opportunities that fit your style even better, so put the full screener toolkit to work for you.

• Target strong value potential by scanning companies flagged as 44 high quality undervalued stocks that may offer quality fundamentals at prices below their assessed worth.
• Prioritise financial strength by filtering for businesses in the solid balance sheet and fundamentals stocks screener (45 results) to focus on sturdier balance sheets and cleaner fundamentals.
• Spot potential early movers by reviewing the screener containing 23 high quality undiscovered gems that have quality metrics yet still sit off most investors' radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.